AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Capstone Holding Corp. Director's Dealing 2017

Jul 24, 2017

35323_dirs_2017-07-24_58f42538-f3bf-44b1-9ca8-b4953199e7f1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2017-07-14

Reporting Person: TOPOREK MICHAEL (Director, See Explanation of Responses)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.0005 par value	0	Direct

Footnotes

F1: The Reporting Person is a member of a Section 13(d) group that owns in the aggregate more than 10% of the Issuer's outstanding shares of Common Stock.